Harvard Bioscience (HBIO) Change in Account Payables (2010 - 2020)
Harvard Bioscience's (HBIO) quarterly Change in Account Payables came in at -$154000.0 in Q4 2020, down 1500.0% year-on-year from $11000.0 in Q1 2020, and up 73.68% on a QoQ basis from -$585000.0 in Q3 2020.
Harvard Bioscience (HBIO) Change in Account Payables (2010 - 2020) Analysis & Trends
Harvard Bioscience (HBIO) has 11 years of Change in Account Payables data on file, last reported at -$154000.0 in Q4 2020.
- On a quarterly basis, Change in Account Payables fell 1500.0% year-over-year to -$154000.0 in Q4 2020; TTM through Dec 2020 was $511000.0, a 124.95% increase from a year earlier, with the FY2020 full-year figure at $511000.0, up 124.95% from the prior year.
- Change in Account Payables for Q4 2020 stood at -$154000.0, up from -$585000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for HBIO reached as high as $2.0 million in Q4 2018 and fell as low as -$2.7 million in Q1 2016.
- Historically, Change in Account Payables has averaged -$163750.0 across 5 years, with a median of -$125000.0 in 2017.
- On a YoY basis, Change in Account Payables climbed as much as 1641.67% in 2018 and fell as far as 2598.8% in 2018.
- Year by year, Change in Account Payables stood at $372000.0 in 2016, then plunged by 135.48% to -$132000.0 in 2017, then soared by 1641.67% to $2.0 million in 2018, then sank by 99.46% to $11000.0 in 2019, then slumped by 1500.0% to -$154000.0 in 2020.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$154000.0 in Q4 2020, -$585000.0 in Q3 2020, and -$72000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -154,000.00 |
| Dec 31, 2020 | -154,000.00 |
| Sep 30, 2020 | -585,000.00 |
| Sep 30, 2020 | -585,000.00 |
| Jun 30, 2020 | -72,000.00 |
| Jun 30, 2020 | -72,000.00 |
| Mar 31, 2020 | 1.32 Mn |
| Mar 31, 2020 | 1.32 Mn |
| Dec 31, 2019 | 11,000.00 |
| Dec 31, 2019 | 11,000.00 |
| Sep 30, 2019 | -677,000.00 |
| Sep 30, 2019 | -677,000.00 |
| Jun 30, 2019 | -1.26 Mn |
| Jun 30, 2019 | -1.26 Mn |
| Mar 31, 2019 | -118,000.00 |
| Mar 31, 2019 | -118,000.00 |
| Dec 31, 2018 | 2.04 Mn |
| Dec 31, 2018 | 2.04 Mn |
| Sep 30, 2018 | -2.24 Mn |
| Sep 30, 2018 | -2.24 Mn |